Codes / ICD10CM / H20.043

H20.043 Secondary noninfectious iridocyclitis, bilateral

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Secondary Noninfectious Iridocyclitis, Bilateral

Summary

Secondary noninfectious iridocyclitis is an inflammatory condition affecting the iris and ciliary body of both eyes. It is classified as secondary because it arises from an underlying systemic or ocular condition, rather than being idiopathic or directly infectious. The inflammation can cause eye discomfort, vision changes, or other complications if not managed appropriately.

Causes

The condition is caused by an underlying noninfectious systemic or ocular disease. Common associations include autoimmune disorders (e.g., sarcoidosis, juvenile idiopathic arthritis), systemic inflammatory conditions, or other ocular diseases that trigger secondary inflammation. The exact mechanism often involves immune-mediated responses targeting the eye structures.

Risk Factors

  • Autoimmune diseases (e.g., sarcoidosis, juvenile idiopathic arthritis)
  • Systemic inflammatory conditions
  • Underlying ocular diseases
  • Previous episodes of iridocyclitis
  • Genetic predisposition to autoimmune disorders

Symptoms

  • Eye redness
  • Eye pain or discomfort
  • Sensitivity to light (photophobia)
  • Blurred vision
  • Tearing
  • Pupil changes (e.g., irregular shape or constriction)

Diagnosis

Diagnosis is typically made through a comprehensive eye examination by an ophthalmologist, including a slit-lamp examination to assess inflammation, visual acuity testing, and possibly additional tests like intraocular pressure measurement or imaging to rule out other conditions. The bilateral nature of the condition is confirmed during examination.

Treatment Options

Treatment focuses on reducing inflammation and managing the underlying cause. This may include topical or systemic corticosteroids, immunosuppressive agents, or medications targeting the associated systemic condition. Regular follow-up is essential to monitor response and adjust therapy.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timely treatment. With appropriate management, inflammation can be controlled, but recurrence is possible. Follow-up care involves regular eye examinations to assess for complications and adjust treatment as needed.

Complications

  • Cataracts
  • Glaucoma
  • Vision loss
  • Synechiae (adhesions between the iris and lens)
  • Chronic inflammation leading to structural eye damage

Lifestyle & Prevention

  • Manage underlying autoimmune or inflammatory conditions as directed by a healthcare provider.
  • Protect eyes from bright light with sunglasses.
  • Avoid known triggers if identifiable.
  • Maintain overall health to support immune function.

When to Seek Professional Help

Seek immediate medical attention if symptoms worsen, vision changes occur, or new symptoms like severe pain or light sensitivity develop. Prompt evaluation is crucial to prevent complications.

Tips for Medical Coders

Document the bilateral nature of the condition clearly in the medical record, as this is a key detail for coding H20.043. Ensure the underlying cause, if known, is also documented to support the secondary classification. Verify that the diagnosis is confirmed by an ophthalmologist and that the condition is noninfectious to align with the code’s specifications.

Book a walkthrough

H20.043 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.